Key result
Low early insulin response during oral glucose tolerance testing predicts progression to overt NIDDM.
Observational
Answers are grounded in this paper and cite their sources.
Reveals that a reduced early insulin response to oral glucose marks definite type 2 diabetes in Japanese subjects, indicating that impaired secretion drives disease pathogenesis.
We studied the plasma insulin response during a 100 g oral glucose tolerance test (OGTT) in subjects with NIDDM and various other conditions associated with glucose intolerance. The criteria for definite diabetes and previously definite diabetes is proposed for those whose fasting blood glucose (FBG) is, or has been, greater than 140 mg dl-1 in the past. A diabetic type glucose tolerance with FBG lower than 140 mg dl-1 was called 'equivocal diabetes'. Insulin response was almost invariably lower in definite diabetes and previously definite diabetes compared to control groups with similar degree of glucose intolerance even in the states of non-diabetic glucose tolerance. This was in contrast to other conditions which are often associated with glucose intolerance such as corticosteroid treatment, post-gastrectomy, liver diseases, in which insulin response is increased with the impairment of glucose tolerance as far as the FBG remains below 140 mg dl-1. The low insulin response in definite diabetes can be represented by a decreased insulinogenic index, the ratio of increment of plasma insulin (muU ml-1) to that of blood glucose (mg dl-1) 30 min after the glucose load. Insulin response was judged to be low when this index was less than 0.5. Low insulin response was a reproducible feature, better than the category of glucose tolerance. It was highly correlated with acute insulin response (AIR) elicited by intravenous glucose injection. The prevalence of low insulin responders was high among groups with a family history of NIDDM. Diabetes with elevated FBG occurred more frequently in low insulin responders than in normal insulin responders. Fasting and 2-h insulin levels are lower in definite diabetes than in control groups with similar blood glucose levels. The so-called inverted-U shape relationship of plasma insulin to blood glucose was not so apparent in definite diabetes. We conclude that a low insulin response to oral glucose, as represented by a low insulinogenic index, is an important inherent characteristic in definite diabetes and probably plays a predominant role in the pathogenesis of NIDDM in most Japanese patients.
No takes yet. Share an insight, caveat, or question.
Kosáka et al. (1996) conducted an observational in Non-insulin-dependent diabetes mellitus (NIDDM) and glucose intolerance. Definite or previously definite NIDDM (fasting blood glucose >140 mg/dL) / Low early insulin response (insulinogenic index <0.5) during 100 g OGTT vs. Control groups with similar degree of glucose intolerance or normal insulin responders (insulinogenic index ≥0.5) was evaluated on Plasma insulin response during a 100 g oral glucose tolerance test, measured by the 30-minute insulinogenic index (ratio of increment of plasma insulin [µU/mL] to blood glucose [mg/dL] at 30 minutes) and progression to diabetes with elevated FBG. Low early insulin response to a 100 g oral glucose load (30-min insulinogenic index <0.5) consistently characterized definite NIDDM (FBG >140 mg/dL) and predicted subsequent overt diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: